Back to Newsroom

Corbus Pharmaceuticals to Present at the Jefferies Cystic Fibrosis Summit

NORWOOD, MA–(Marketwired – September 19, 2016) – Corbus Pharmaceuticals Holdings, Inc.(NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical stage drug development company targeting rare, chronic, serious inflammatory and fibrotic diseases, announced today that Yuval Cohen, Ph.D., Chief Executive Officer, will present at the Jefferies Cystic Fibrosis Summit on Thursday, September 29 at 1:15 p.m. ET in New York, NY.

Click here to read the full release